Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
66 studies found for:    "Smallpox"
Show Display Options
Rank Status Study
1 Completed Dressing Preparations for Smallpox
Condition: Smallpox
Intervention: Biological: Wetvax (APSV)
2 Completed
Has Results
Effect of Dose, Safety, Tolerability of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination
Condition: Smallpox
Interventions: Biological: Vaccinia virus: ACAM2000 smallpox vaccine;   Biological: vaccinia virus (calf lymph): Dryvax
3 Completed Safety and Efficacy of CJ Smallpox Vaccine in Healthy Volunteers
Condition: Smallpox
Intervention: Drug: smallpox vaccine CJ-50300
4 Completed Safety and Efficacy of CJ Smallpox Vaccine in Previously Vaccinated Healthy Volunteers
Condition: Smallpox
Intervention: Drug: smallpox vaccine CJ-50300
5 Completed A Long-Term Study of Healthy Adults Vaccinated With One Dose of Smallpox Vaccine (LISTER Strain)
Condition: Smallpox
Intervention:
6 Completed Study of Reactogenicity, Safety, Immunogenicity, and Pock Lesion Formation of a Cell-Cultured Smallpox Vaccine Compared to Dryvax®
Condition: Smallpox
Intervention: Biological: Cell-Cultured Smallpox Vaccine compared to Dryvax®
7 Completed A Randomized, Double-blind, Placebo-controlled Study on Immunogenicity and Safety of MVA-BN (IMVAMUNE™) Smallpox Vaccine in Healthy Subjects
Condition: Smallpox
Interventions: Biological: MVA-BN® (IMVAMUNE);   Biological: IMVAMUNE
8 Completed
Has Results
Dose Study of ACAM2000 Smallpox Vaccine in Previously Vaccinated Adults
Condition: Smallpox
Interventions: Biological: ACAM2000 Smallpox Vaccine;   Biological: Vaccinia virus (calf lymph) smallpox vaccine: Dryvax®
9 Completed Human Immune Responses Smallpox
Condition: Smallpox
Intervention: Biological: Dryvax
10 Completed A Study of Dryvax Vaccine Against Smallpox in Previously Unvaccinated Adults
Condition: Smallpox
Intervention: Biological: Dryvax vaccine
11 Completed Dose-finding Study to Evaluate Immunogenicity of Three Different Dose Levels of the IMVAMUNE (MVA-BN) Smallpox Vaccine.
Condition: Smallpox
Intervention: Biological: IMVAMUNE (MVA-BN)
12 Terminated Dose Safety, Tolerability, and Immunogenicity of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination
Condition: Smallpox
Interventions: Biological: ACAM1000;   Biological: vaccinia virus (calf lymph) smallpox vaccine: Dryvax
13 Completed Phase 2 Study of Safety, Tolerability, and Immunogenicity of Three Dose Levels of ACAM3000 Smallpox Vaccine
Condition: Smallpox
Interventions: Drug: MVA Smallpox vaccine;   Drug: Placebo
14 Completed Safety, Tolerability, and Immune Response of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in Adults
Condition: Smallpox
Intervention: Biological: ACAM3000 MVA Vaccine
15 Completed Take Rate, Immunogenicity and Safety of Elstree-BN Smallpox Vaccine in Healthy Vaccinia-Naive Subjects
Condition: Smallpox
Intervention: Biological: Elstree-BN
16 Completed A Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects
Condition: Smallpox
Intervention: Biological: IMVAMUNE
17 Completed A Phase II Trial to Compare a Liquid-frozen and a Freeze-dried Formulation of IMVAMUNE (MVA-BN®) Smallpox Vaccine in Vaccinia-naïve Healthy Subjects
Condition: Smallpox
Interventions: Biological: LF formulation of IMVAMUNE®;   Biological: FD formulation of IMVAMUNE®
18 Completed A Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Healthy, Vaccinia-naïve Subjects
Condition: Smallpox
Interventions: Biological: IMVAMUNE®;   Other: Placebo
19 Enrolling by invitation VA-005 Clinical Outcomes of VIGIV Treatment of Smallpox Vaccination Complications or Vaccinia Infection
Condition: Complication of Smallpox Vaccination
Intervention: Biological: VIGIV
20 Completed MVA Post-Event: Administration Timing and Boost Study
Condition: Smallpox
Interventions: Drug: Placebo (subcutaneous);   Drug: Placebo (scarification);   Biological: Dryvax®;   Biological: IMVAMUNE®

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.